聚烯薄膜的功能化与2- ((Diethylamino) 乙烯甲基酸盐用于双刺激响应药物加载和释放研究
José M Pérez-Larios1, Miguel S Pérez-Garibay1, Emilio Bucio1
1Departamento de Química de Radiaciones y Radioquímica, Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Mexico City 04510, Mexico.
Polymers
|January 10, 2026
概括
这项研究修改了具有pH值和温度响应单体的聚烯薄膜,创造了用于药物输送的材料. 功能化片显示出改善的特性和生物医学应用的潜力.
科学领域:
- 材料科学 材料科学 材料科学
- 聚合物化学 聚合物化学
- 生物医学工程 生物医学工程
背景情况:
- 聚烯 (PP) 薄膜缺乏刺激反应性质.
- 聚合物的功能化是开发先进材料的关键.
- 响应刺激的聚合物为特定应用提供可调节的特性.
研究的目的:
- 使用玛射线照射,将聚烯薄膜功能化为2-乙氨基乙基甲酸盐 (DEAEM).
- 以其热,化学和物理性能来表征改性薄膜 (PP-g-DEAEM).
- 评估PP-g-DEAEM薄膜对于西普罗夫洛克萨加载,释放和抗菌有效性的潜力.
主要方法:
- 马射线辐射将DEAEM接种到PP膜上.
- 使用热分析,FTIR-ATR,胀和接触角测量进行表征.
- 在体外药物加载/释放研究和对大肠杆菌的抗菌试验.
主要成果:
- 确认了DEAEM在PP薄膜上的成功接种.
- 增强的湿透性,临界pH值为5.6,温度响应在45.7°C.
- 证明了西普罗夫洛克萨加载/释放和体外对大肠杆菌的疗效.
结论:
- PP-g-DEAEM 电影表现出可调节的刺激反应行为.
- 经过修改的片对药物输送系统和生物医学设备有很大的前景.
- 需要进一步的研究来探索这些功能化电影的全部潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


